Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1222 | Clinical Cases–Pituitary/Adrenal | ECE2015

Glucocorticoid resistance syndrome: case report

Neves Ana Carolina , Fonseca Fernando , Agapito Ana

Introduction: Glucocorticoid resistance syndrome (GRS) is a rare familial or sporadic condition, caused by mutations in glucocorticoid receptor gene. It is characterised by generalised partial resistance of target tissues to cortisol action and compensatory elevation of ACTH with subsequent hypersecretion of cortisol, mineralocorticoids and androgens. Its clinical spectrum is broad and it may occur with high blood pressure (HBP) metabolic alcalosis, hypokalaemia and virilisati...

ea0081p611 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Influence of dopamine receptor d2 and dopamine transporter polymorphisms in angiopathy in patients with type 2 diabetes mellitus

Neves Marta , Santos Ana Carolina , Ferreira Joana , Raposo Joao F. , Valente Ana , Bicho Manuel

Introduction and Aim: Dopamine receptor D2 (DRD2) polymorphism (rs1800497) appears to be associated with increased susceptibility to the development of type 2 diabetes mellitus (T2DM). The dopamine transporter (DAT) determines dopamine signalling, responsible for the reuptake of its active form from the synapse. Polymorphism in the DAT gene (rs2836317) can increase dopamine reuptake in the synaptic cleft. However, its association with T2DM is still controversial.<p class="...

ea0037ep1297 | Clinical Cases–Thyroid/Other | ECE2015

Familial hypocalciuric hypercalcaemia: case report

Neves Ana Carolina , Rego Teresa , Cavaco Branca , Fonseca Fernando , Agapito Ana

Introduction: Familial hypocalciuric hypercalcaemia (FHH) is a rare genetically heterogeneous disorder, with 3 variants described. An inactivating mutation in the calcium sensor receptor (CASR) gene causes the subtype 1, which represents 65% of the cases.It is charaterised by hypercalcaemia and hypocalciuria with normal or elevated PTH. FHH is generally assymptomatic and treatment is not needed. Differential diagnosis with primary hyperparathyroidism (PH...

ea0056gp114 | Diabetes Translational | ECE2018

Benefits of the association of triiodothyronine (T3) to insulin treatment for the glycemic control of alloxan-induced diabetic rats

Florido-Neto Armando , Agostini Lucas , Panveloski-Costa Ana Carolina , Nunes Maria Tereza

Diabetes mellitus (DM) is a disease that results from impairment of insulin synthesis/secretion or signaling. The glycemia of type 1 DM (DM1) patients is controlled by insulin replacement therapy, which chronically results in insulin resistance. We have shown that alloxan-induced diabetic rats present hypothyroidism, and that T3 treatment reduced the inflammatory state and hepatic glucose production and increased insulin sensitivity, improving glycemia control. Considering tha...

ea0056p867 | Pituitary - Clinical | ECE2018

Clinical and mri findings among 120 patients with macroproprolactinemia: results from a retrospective study

Vilar Lucio , Vilar Clarice , Albuquerque Luciano , The Ana Carolina , Trovao Erik , Gadelha Patricia , Lyra Ruy

Background: Macroprolactinemia is a condition where more of 60% of circulating PRL is made up of macroprolactin. It may be observed in both sexes (although women represent about 90% of published cases), and at all ages. As macroprolactin has low biological active and low bioavailibility, most patients are asymptomatic. The Endocrine Society guidelines recommend screening for macroprolactin only in asymptomatic hyperprolactinemic patients. However, some data from the literature...

ea0073aep228 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Association of IDO polymorphism with oxidative status, metabolic control and inflammation in patients with type 2 diabetes mellitus

Neves Marta , Bicho Manuel , Santos Ana Carolina , João F. Raposo , Valente Ana

IntroductionThe Indoleamine 2.3-dioxygenase (IDO) is an enzyme involved in tryptophan metabolism, encoded by the IDO1 gene in humans. In Caucasians, the rs9657182 polymorphism of IDO gene was found to be associated with neurobehavioral complications, especially depression. Several studies in Type 2 Diabetes Mellitus (T2DM) describe psychological factors as barriers to the successful implementation of a healthy eating plan. According to our knowledge ther...

ea0081p550 | Calcium and Bone | ECE2022

Biochemical parameters in metabolic bone disease of obese patients

Binda Pereira Raquel , Santos Ana Carolina , Ferreira Joana , Mascarenhas Mario Rui , De Quinhones Levy Pilar , Barbosa Paula , Bicho Manuel

Introduction: Obesity is a pathological condition characterized by a low-grade systemic inflammatory state that predisposes to the onset of some diseases, such as hypertension, diabetes, and hyperlipidemia. Also, obesity can impact bone metabolism, but its effects are controversial.Aims: This observational study aimed to evaluate and correlate the bone mass with the lipidic profile, adipocytokines, glucose metabolism, hepatic function and purine metaboli...

ea0063p1093 | Pituitary and Neuroendocrinology 3 | ECE2019

Medical treatment of cushing’s disease during pregnancy with Ketoconazole and Cabergoline – Report of 3 cases

Vilar Lucio , Vilar Clarice , Albuquerque Luciano , Gadelha Patricia , The Ana Carolina , Trovao Erik , Sampaio Icaro , Ferreira Liana , Lyra Ruy

Abstract: Cushing’s syndrome (CS) during pregnancy is a rare condition with fewer an 200 cases reported in the literature, However, because CS results in increased fetal and maternal complications, its early diagnosis and treatment are critical. During pregnancy, 40-50% of cases are caused by adrenal adenomas, while Cushing’s disease (CD) accounts for only one third of the cases. We describe here 3 patients with CD who needed to be treated during pregnancy.<p cla...

ea0063p1113 | Pituitary and Neuroendocrinology 3 | ECE2019

The impact of clomiphene citrate as add-on therapy in male acromegalic patients non-responsive to combined medical therapy

Vilar Lucio , Vilar Clarice , Albuquerque Luciano , Trovao Erik , The Ana Carolina , Gadelha Patricia , Campos Renata , Cardoso Izabela , Borges Thaise , Lyra Ruy

Introduction: Clomiphene citrate (CC), a selective estrogen receptor modulator that increases LH and FSH secretion, improves hypogonadism and fertility outcomes. Moreover, there is limited evidence that it may also be helpful as add-on therapy to normalize IGF-1 levels in male acromegalic patients.Objective: To assess the effect impact of CC on serum IGF-1 and testosterone levels in male acromegalic patients not controlled by the combination of lanreotid...

ea0049ep716 | Obesity | ECE2017

Thyroid hormone treatment reduces inflammatory cytokines in mesenteric adipose tissue improving insulin sensitivity of obese rats

Panveloski-Costa Ana Carolina , Serrano-Nascimento Caroline , Poyares Leonice , Viana Gabriela Souza , Bargi-Souza Paula , Nunes Maria Tereza

Thyroid hormone plays an important role on carbohydrate and lipid metabolism. In hypothyroidism is observed reduction of glucose transporter-4 expression and insulin sensitivity and in hyperthyroid states the key enzymes of gluconeogenesis and glycogenolysis are induced, and both conditions lead to glucose intolerance. It has been reported an increased prevalence of thyroid dysfunction in obese and diabetic patients. Recently we have demonstrated a hypothyroid state in alloxan...